Colorectal CancerJim Cassidy, Patrick Johnston, Eric Van Cutsem CRC Press, 11 sept 2006 - 349 páginas Written by world authorities on the subject, this reference comprehensively covers every aspect of colorectal cancer. Addressing the molecular mechanisms, genetics, identification, and therapy of disease, this guide covers new pharmaceutical developments, current screening protocols, and modern methods of disease management by specialists at renown |
Índice
| 1 | |
Chapter 2 Epidemiology of Colorectal Cancer | 43 |
Chapter 3 Colorectal Cancer Screening | 77 |
Chapter 4 Pathology | 103 |
Chapter 5 Familial Cancer Management | 125 |
Chapter 6 The Surgical Principles of Managing Colorectal Cancer | 151 |
Chapter 7 Adjuvant Therapy for Colorectal Cancer | 163 |
Chapter 8 The Role of Radiotherapy in the Treatment of Rectal Cancer | 195 |
Chapter 9 The Treatment of Metastatic Colorectal Cancer | 229 |
Chapter 10 Hepatic Directed Therapy | 253 |
Chapter 11 Pharmacogenomics of Colorectal Cancer | 287 |
Chapter 12 Drug Development for Advanced Colorectal Cancer in the United States | 317 |
| 337 | |
Back cover | 353 |
Otras ediciones - Ver todo
Colorectal Cancer Jim Cassidy,Patrick Johnston,Eric Van Cutsem No hay ninguna vista previa disponible - 2006 |
Términos y frases comunes
activity addition adenomas adjuvant advanced colorectal cancer agents analysis approach associated benefit bevacizumab bowel carcinoma cause cells cetuximab chemotherapy Clin Oncol clinical colon cancer combination compared demonstrated difference disease dose drug effect et al evidence excision expression families fluorouracil gene genetic growth factor hepatic arterial hereditary higher HNPCC human identified important improved incidence increased individuals infusion involved irinotecan leucovorin levels liver median metastatic colorectal cancer months mutations observed Oncology overall oxaliplatin patients phase polymorphism polyposis polyps population postoperative predictive preoperative present progression radiotherapy randomized randomized trial received recent receptor rectal cancer rectum recurrence reduced regimen repair reported resection response response rate risk role screening setting showed shown significant stage suggest Surg surgery surgical survival syndrome systemic Table testing therapy tion toxicity treated treatment tumor United variants versus